OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 10, 2022
Democrats approve curbs for Medicare plans, but not for commercial drug coverage.
August 04, 2022
Better clinical data are needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.
August 02, 2022
FDA’s hybrid inspection model will remain a regular means for supplementing onsite inspections and will be further integrated into the agency’s oversight operations.
July 26, 2022
Scrutiny of accelerated approvals has generated a range of reform proposals to accelerate the conduct of confirmatory studies.
July 14, 2022
Application for OTC contraceptive highlights efforts to broaden access to medicines.
July 08, 2022
Some states look to block access to approved drugs.
June 27, 2022
Regulators wish to expand and clarify methods for obtaining information on medicines used by or needed for pregnant and lactating individuals through clinical trials and postapproval studies.
June 22, 2022
FDA is at a pivotal moment because of important gains in medical treatment based on science.
June 17, 2022
Measure tackles infant formula, cosmetics, diagnostics plus drug development and access.
June 01, 2022
Manufacturers are aligning with pharmacists and providers to blame high drug costs and limited patient access on pharmacy benefit managers.